Compare Pfizer with Unichem Lab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs UNICHEM LAB - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER UNICHEM LAB PFIZER/
UNICHEM LAB
 
P/E (TTM) x 33.5 60.5 55.3% View Chart
P/BV x 5.6 0.7 863.2% View Chart
Dividend Yield % 0.6 2.1 28.5%  

Financials

 PFIZER   UNICHEM LAB
EQUITY SHARE DATA
    PFIZER
Mar-18
UNICHEM LAB
Mar-19
PFIZER/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs2,365292 809.9%   
Low Rs1,625182 892.9%   
Sales per share (Unadj.) Rs430.3167.7 256.6%  
Earnings per share (Unadj.) Rs78.7-3.6 -2,167.7%  
Cash flow per share (Unadj.) Rs93.25.9 1,568.3%  
Dividends per share (Unadj.) Rs20.004.00 500.0%  
Dividend yield (eoy) %1.01.7 59.4%  
Book value per share (Unadj.) Rs586.5372.3 157.6%  
Shares outstanding (eoy) m45.7570.38 65.0%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x4.61.4 328.0%   
Avg P/E ratio x25.3-65.3 -38.8%  
P/CF ratio (eoy) x21.439.9 53.7%  
Price / Book Value ratio x3.40.6 534.3%  
Dividend payout %25.4-110.2 -23.1%   
Avg Mkt Cap Rs m91,27116,680 547.2%   
No. of employees `0002.62.6 101.1%   
Total wages/salary Rs m3,1432,393 131.3%   
Avg. sales/employee Rs Th7,484.84,535.2 165.0%   
Avg. wages/employee Rs Th1,195.0919.8 129.9%   
Avg. net profit/employee Rs Th1,369.1-98.2 -1,394.1%   
INCOME DATA
Net Sales Rs m19,68511,801 166.8%  
Other income Rs m1,143984 116.1%   
Total revenues Rs m20,82812,785 162.9%   
Gross profit Rs m5,003-835 -599.2%  
Depreciation Rs m663674 98.3%   
Interest Rs m475 5.6%   
Profit before tax Rs m5,479-600 -913.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,878-343 -546.9%   
Profit after tax Rs m3,601-256 -1,409.1%  
Gross profit margin %25.4-7.1 -359.2%  
Effective tax rate %34.357.3 59.9%   
Net profit margin %18.3-2.2 -844.7%  
BALANCE SHEET DATA
Current assets Rs m24,16720,384 118.6%   
Current liabilities Rs m9,5445,029 189.8%   
Net working cap to sales %74.3130.1 57.1%  
Current ratio x2.54.1 62.5%  
Inventory Days Days55105 52.6%  
Debtors Days Days29135 21.3%  
Net fixed assets Rs m9,5149,023 105.4%   
Share capital Rs m458141 324.9%   
"Free" reserves Rs m26,37526,058 101.2%   
Net worth Rs m26,83226,199 102.4%   
Long term debt Rs m250-   
Total assets Rs m36,90031,496 117.2%  
Interest coverage x1,305.5-7.0 -18,718.2%   
Debt to equity ratio x00-  
Sales to assets ratio x0.50.4 142.4%   
Return on assets %9.8-0.6 -1,706.3%  
Return on equity %13.4-1.0 -1,375.9%  
Return on capital %20.4-2.0 -1,021.2%  
Exports to sales %069.4 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA8,188 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m228,188 0.3%   
Fx outflow Rs m1,489596 249.8%   
Net fx Rs m-1,4667,592 -19.3%   
CASH FLOW
From Operations Rs m3,318-3,278 -101.2%  
From Investments Rs m-2,383-2,860 83.3%  
From Financial Activity Rs m-1,104-24 4,559.9%  
Net Cashflow Rs m-169-4,690 3.6%  

Share Holding

Indian Promoters % 0.0 50.1 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 15.1 49.7%  
FIIs % 4.9 3.0 163.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 31.7 74.8%  
Shareholders   85,207 20,176 422.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   CADILA HEALTHCARE  TTK HEALTHCARE  ORCHID PHARMA LTD  DISHMAN PHARMA  J.B.CHEMICALS  

Compare PFIZER With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Strengthening Rupee, Inflation & Factory Output Data, and Top Stocks in Action Today(Pre-Open)

On Friday, Indian share markets witnessed most of the buying interest during closing hours and ended on a strong note.

Related Views on News

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

UNICHEM LAB Announces Quarterly Results (4QFY19); Net Profit Up 31.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, UNICHEM LAB has posted a net profit of Rs 37 m (up 31.7% YoY). Sales on the other hand came in at Rs 3 bn (up 35.1% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

PFIZER Announces Quarterly Results (4QFY19); Net Profit Up 4.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, PFIZER has posted a net profit of Rs 1 bn (up 4.7% YoY). Sales on the other hand came in at Rs 5 bn (up 3.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Sep 13, 2019 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS